drugset / Trial / NCT01893437

A Study of RO6799477 in Healthy Volunteers

NCT01893437 ↗

Phase 1 Completed 27 enrolled Hoffmann-La Roche
RandomizedParallel-groupDouble-blind

Summary

This single-center, randomized, double-blind, placebo-controlled, single dose study will investigate the safety, pharmacokinetics, pharmacodynamics of RO6799477 in healthy volunteers.

Timeline

Start
2013-07
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject RO6799477 Unknown — Oral

Indications

No indication recorded.